The FLI-1 protein has been shown to show certain effectiveness in the identification of vascular tumors, including EHE, and it was also recognized as an endothelial cell marker with a combined sensitivity and specificity superior to those of widely used endothelial markers alone [21, 22]. The gene discussed is FLI1; the disease is vascular neoplasm.